Displaying 121 - 130 of 976 results for "The Drug Rehab Agency headquarters address"
-
Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki | Thirteenth Annual Report of the Perinatal and Maternal Mortality Review Committee
The Thirteenth Annual Report of the Perinatal and Maternal Mortality Review Committee | Te Pūrongo ā-Tau Tekau mā Toru o te Komiti Arotake Mate Pēpi, Mate Whaea Hoki.
-
Communications toolkit for the home and community support services experience survey
This toolkit is a guide on promoting the 2025 home and community support services experience survey to raise awareness and encourage people to take part.
- Further reading, articles and resources of interest
-
Presentations from the Surgical Site Infection Improvement Programme champions meetings
Presentations from the Surgical Site Infection Improvement Programme champions meetings are available to download on this page.
- Appropriate use of antibiotics in the management of urinary tract infections
-
Describing the quality of New Zealand's health and disability services
Health Quality and Safety Indicator report 'Describing the quality of New Zealand's health and disability services'.
-
A guide to implementing light surveillance for the orthopaedic SSIIP
This document outlines the process for undertaking ‘light surveillance’ for the orthopaedic SSIIP. It supplements the Orthopaedic surgery implementation manual.
-
Surgical briefings are an efficient way to start the day
Briefings take just five minutes and have a significant and positive impact on patient safety by improving communication and teamwork, reducing delays and identifying potential risks prior to surgery.
-
Vicki Culling discusses the Perinatal and Maternal Mortality Review Committee
Vicki Culling from the Perinatal and Maternal Mortality Review Committee (PMMRC) discusses the loss of her first baby from a still birth, and her involvement as a consumer representative on the PMMRC.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3